Gustavo Scola PT, MBiotech, Ph.D.

Dr. Gustavo Scola PT, MBiotech, Ph.D.

R&D, AGENSCIA I Science at Scale, Campinas, São Paulo, Brazil
orcid
www.agenscia.com.br

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2007 in Atherosclerosis
Verified
Journal Article
Closed access
PJPaulo Ivo Homem de Bittencourt Jr.
Paulo Ivo Homem de Bittencourt Jr.
DLDenise J. Lagranha
Denise J. Lagranha
AMAlexandre Maslinkiewicz
Alexandre Maslinkiewicz
SSSueli M. Senna
Sueli M. Senna
ATAngela M.V. Tavares
Angela M.V. Tavares
RCRui Curi
Rui Curi

1 March 2013 in Brain Research Bulletin
Verified
Journal Article
Closed access
Catia Santos BrancoCatia Santos Branco
Catia Santos Branco
Gustavo Scola PT, MBiotech, Ph.D.Gustavo Scola PT, MBiotech, Ph.D.
Gustavo Scola PT, MBiotech, Ph.D.
ARAdriana Dalpicolli Rodrigues
Adriana Dalpicolli Rodrigues
VCVerónica Cesio
Verónica Cesio
MLMariajosé Laprovitera
Mariajosé Laprovitera
MSMirian Salvador
Mirian Salvador

1 January 2015 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
Gustavo Scola PT, MBiotech, Ph.D.Gustavo Scola PT, MBiotech, Ph.D.
Gustavo Scola PT, MBiotech, Ph.D.
AAAna C. Andreazza
Ana C. Andreazza

1 June 2012 in Neurochemistry International
Verified
Journal Article
Closed access
ARAdriana Dalpicolli Rodrigues
Adriana Dalpicolli Rodrigues
TSThamiris Becker Scheffel
Thamiris Becker Scheffel
Gustavo Scola PT, MBiotech, Ph.D.Gustavo Scola PT, MBiotech, Ph.D.
Gustavo Scola PT, MBiotech, Ph.D.
MSMaitê Telles dos Santos
Maitê Telles dos Santos
BFBruna Fank
Bruna Fank
MSMirian Salvador
Mirian Salvador

1 January 2013 in Biological Psychiatry
Verified
Journal Article
Closed access
Gustavo Scola PT, MBiotech, Ph.D.Gustavo Scola PT, MBiotech, Ph.D.
Gustavo Scola PT, MBiotech, Ph.D.
HKHelena Kyunghee Kim
Helena Kyunghee Kim
LYL. Trevor Young
L. Trevor Young
AAAna Cristina Andreazza
Ana Cristina Andreazza

1 January 2016 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
AMAlencar Machado
Alencar Machado
AAAna Cristina Andreazza
Ana Cristina Andreazza
TSTatiane Morgana Da Silva
Tatiane Morgana Da Silva
ABAline Augusti Boligon
Aline Augusti Boligon
VNVanusa Do Nascimento
Vanusa Do Nascimento
ICIvana Beatrice Beatrice Mânica Mânica Da Cruz
Ivana Beatrice Beatrice Mânica Mânica Da Cruz
Neuropsychiatric diseases, such as bipolar disorder (BD) and schizophrenia (SCZ), have a very complex pathophysiology. Several current studies describe an association between psychiatric illness and mitochondrial dysfunction and consequent cellular modifications, including lipid, protein, and DNA damage, caused by cellular oxidative stress. Euterpe oleracea (açaí) is a powerful antioxidant fruit. Açaí is an Amazonian palm fruit primarily found in the lowlands of the Amazonian rainforest, particularly in the floodplains of the Amazon River. Given this proposed association, this study analyzed the potential in vitro neuropharmacological effect of Euterpe oleracea (açaí) extract in the modulation of mitochondrial function and oxidative metabolism. SH‐SY5Y cells were treated with rotenone to induce mitochondrial complex I dysfunction and before and after we exposed the cells to açaí extract at 5 μg/mL. Treated and untreated cells were then analyzed by spectrophotometric, fluorescent, immunological, and molecular assays. The results showed that açaí extract can potentially increase protein amount and enzyme activity of mitochondrial complex I, mainly through NDUFS7 and NDUFS8 overexpression. Açaí extract was also able to decrease cell reactive oxygen species levels and lipid peroxidation. We thus suggest açaí as a potential candidate for drug development and a possible alternative BD therapy.